| Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States NJ Dharan, LV Gubareva, JJ Meyer, M Okomo-Adhiambo, RC McClinton, ... Jama 301 (10), 1034-1041, 2009 | 919 | 2009 |
| Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen MG Cormican, SA Marshall, RN Jones Journal of Clinical Microbiology 34 (8), 1880-1884, 1996 | 344 | 1996 |
| Nosocomial enterococcal blood stream infections in the SCOPE program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy RN Jones, SA Marshall, MA Pfaller, WW Wilke, RJ Hollis, ME Erwin, ... Diagnostic microbiology and infectious disease 29 (2), 95-102, 1997 | 205 | 1997 |
| Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA … SA Marshall, WW Wilke, MA Pfaller, RN Jones Diagnostic microbiology and infectious disease 30 (3), 205-214, 1998 | 188 | 1998 |
| Comparison of Cefoxitin and Oxacillin Disk Diffusion Methods for Detection of mecA-Mediated Resistance in Staphylococcus aureus in a Large-Scale Study NM Broekema, TT Van, TA Monson, SA Marshall, DM Warshauer Journal of clinical microbiology 47 (1), 217-219, 2009 | 183 | 2009 |
| Inducible amp C β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national … MA Pfaller, RN Jones, SA Marshall, SL Coffman, RJ Hollis, MB Edmond, ... Diagnostic microbiology and infectious disease 28 (4), 211-219, 1997 | 135 | 1997 |
| Comparison of Agar Diffusion Methodologies for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients JL Burns, L Saiman, S Whittier, D Larone, J Krzewinski, Z Liu, SA Marshall, ... Journal of Clinical Microbiology 38 (5), 1818-1822, 2000 | 108 | 2000 |
| Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States SB Graitcer, L Gubareva, L Kamimoto, S Doshi, M Vandermeer, J Louie, ... Emerging infectious diseases 17 (2), 255, 2011 | 95 | 2011 |
| Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates … T Yamazumi, SA Marshall, WW Wilke, DJ Diekema, MA Pfaller, RN Jones Journal of clinical microbiology 39 (1), 53-56, 2001 | 95 | 2001 |
| Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients JL Burns, L Saiman, S Whittier, J Krzewinski, Z Liu, D Larone, SA Marshall, ... Diagnostic microbiology and infectious disease 39 (4), 257-260, 2001 | 75 | 2001 |
| Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance MA Pfaller, RN Jones, SA Marshall, MB Edmond, RP Wenzel Diagnostic microbiology and infectious disease 29 (4), 259-263, 1997 | 75 | 1997 |
| Cellular protein synthesis and inhibition of cell division are independent of butyrate-induced histone hyperacetylation P Rubenstein, L Sealy, S Marshall, R Chalkley Nature 280 (5724), 692-693, 1979 | 74 | 1979 |
| Antimicrobial activity of cefepime tested against bush group I β-lactamase-producing strains resistant to ceftazidime a multilaboratory national and international clinical … RN Jones, SA Marshall Diagnostic microbiology and infectious disease 19 (1), 33-38, 1994 | 55 | 1994 |
| Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program WW Wilke, SA Marshall, SL Coffman, MA Pfaller, MB Edmund, RP Wenzel, ... Diagnostic microbiology and infectious disease 29 (1), 43-49, 1997 | 53 | 1997 |
| Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur … SA Marshall, RN Jones, A Wanger, JA Washington, GV Doern, AL Leber, ... Journal of clinical microbiology 34 (8), 2027-2029, 1996 | 53 | 1996 |
| Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of … RN Jones, MA Pfaller, SA Marshall, RJ Hollis, WW Wilke Diagnostic microbiology and infectious disease 29 (3), 187-192, 1997 | 52 | 1997 |
| In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone SA Marshall, RN Jones Antimicrobial agents and chemotherapy 37 (12), 2747-2753, 1993 | 47 | 1993 |
| Comparison of activities of broad-spectrum β-lactam compounds against 1,128 Gram-positive cocci recently isolated in cancer treatment centers DJ Diekema, SL Coffman, SA Marshall, ML Beach, KVI Rolston, RN Jones Antimicrobial agents and chemotherapy 43 (4), 940-943, 1999 | 39 | 1999 |
| Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years SA Marshall, KE Aldridge, SD Allen, PC Fuchs, EH Gerlach, RN Jones Diagnostic microbiology and infectious disease 21 (3), 153-168, 1995 | 39 | 1995 |
| Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime RN Jones, DJ Biedenbach, SA Marshall, MA Pfaller, GV Doern Diagnostic microbiology and infectious disease 32 (2), 107-110, 1998 | 33 | 1998 |
